Contact

Dr. Holger Stephan
Radionuclide Theragnostics
h.stephanAthzdr.de
Phone: +49 351 260 - 3091
Fax: 13091, 3232

Nanomaterials



The application of nanomaterials (NMs) in biomedicine is increasing rapidly and offers excellent prospects for the development of new non-invasive strategies for the diagnosis and treatment of cancer. One major advantage of NMs is their potential to be used as non-invasive diagnostic tools. By combining multiple modalities into a single probe, higher sensitivity can be achieved and thus deeper insight gained into different in vitro and in vivo processes.

References

J. A. Barreto, W. O’Malley, M. Kubeil, B. Graham, H. Stephan, L. Spiccia
Nanomaterials: applications in cancer imaging and therapy
Adv. Mater. 2011, 23, H18-H40.

K. Pombo-García, K. Zarschler, J. A. Barreto, J. Hesse, L. Spiccia, B. Graham, H. Stephan
Design, synthesis, characterisation and in vitro studies of hydrophilic, colloidally-stable, 64Cu(II)-labelled, ultra-small iron oxide nanoparticles in a range of human cell lines
RSC Adv.2013, 3, 22443-22454.


Contact

Dr. Holger Stephan
Radionuclide Theragnostics
h.stephanAthzdr.de
Phone: +49 351 260 - 3091
Fax: 13091, 3232